STOCK TITAN

Silk Road Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Silk Road Medical (NASDAQ: SILK) announced its participation in the 40th Annual J.P. Morgan Healthcare Conference, scheduled for January 12, 2022, at 3:45 p.m. ET. The presentation will focus on the company’s innovative approach to reducing stroke risk, specifically through its TransCarotid Artery Revascularization (TCAR) procedure. Interested parties can access the live and archived webcast via the company’s Investors section on its website. The company aims to improve patient outcomes through advanced clinical techniques.

Positive
  • None.
Negative
  • None.

SUNNYVALE, Calif., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference.

Silk Road Medical’s management is scheduled to present on Wednesday, January 12, 2022 at 3:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com


FAQ

When is Silk Road Medical's presentation at the J.P. Morgan Healthcare Conference?

Silk Road Medical is scheduled to present on January 12, 2022, at 3:45 p.m. Eastern Time.

How can I access the Silk Road Medical conference presentation?

You can access the live and archived webcast of Silk Road Medical's presentation on the Investors section of their website.

What is the focus of Silk Road Medical's presentation at the conference?

The presentation will focus on reducing stroke risk and their innovative TransCarotid Artery Revascularization (TCAR) procedure.

What does Silk Road Medical do?

Silk Road Medical specializes in medical devices aimed at reducing the risk of stroke, particularly through the TCAR procedure.

Silk Road Medical, Inc.

NASDAQ:SILK

SILK Rankings

SILK Latest News

SILK Stock Data

1.12B
40.63M
4.15%
97.46%
7.75%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SUNNYVALE